Eli Lilly & Co. just announced that they are going to buy Sigilon Therapeutics for $14.92 per share. Why are they buying it for a much higher share price than through the stock exchange where the closed quote was $3.93 per share?
In: 53
Sigilon Therapeutics’ board (the big boys and girls who make the decisions) thought that $14.92 was a fair price if someone wanted to buy ALL the pieces of their company.
Like if you had a pizza and that pizza was all you had, you would probably want to sell it for a lot so you never had to make pizza again and could go on to buy other fun things later in life.
Latest Answers